Equities

Maja Agung Latexindo PT Tbk

SURI:JKT

Maja Agung Latexindo PT Tbk

Actions
Health CareMedical Equipment and Services
  • Price (IDR)288.00
  • Today's Change0.00 / 0.00%
  • Shares traded37.32m
  • 1 Year change--
  • Beta--
Data delayed at least 10 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Maja Agung Latexindo Tbk is an Indonesia-based company, which is engaged in manufacturing gloves. The Company’s products include examination gloves, industrial gloves, and specialty gloves. It serves various industries, including medical and healthcare, industrial sector, and beauty care.

  • Revenue in IDR (TTM)--
  • Net income in IDR--
  • Incorporated--
  • Employees167.00
  • Location
    Maja Agung Latexindo PT TbkNorth Sumatra 20352IndonesiaIDN
  • Phone+62 618459170
  • Websitehttps://malgloves.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cyclopharm Limited342.49bn-49.99bn1.65tn87.00--4.81--4.83-0.0508-0.05080.34760.34280.67481.114.13370,173.10-9.85-12.60-11.92-14.9468.1570.20-14.60-25.472.32-18.400.1159--11.2215.5028.90---7.83--
Vasa Denticity Ltd235.19bn14.50bn1.69tn184.00116.4855.94108.817.184.754.7576.969.88----------------24.67--6.17--0.538979.600.0606--60.25--52.14------
Mach7 Technologies Ltd286.81bn-59.05bn1.72tn90.00--2.9774.685.99-0.0231-0.02310.11230.22560.3605--3.21---7.42-7.48-8.73-8.6595.0993.72-20.59-20.56---2,605.170.0193--10.9728.3074.85--29.28--
HOSHI IRYO-SANKI CO., LTD1.51tn142.81bn1.75tn470.0011.170.91187.381.16447.23447.234,742.975,478.130.667434.485.35--6.375.668.077.1948.7849.049.558.652.86--0.045815.747.256.4211.159.87-13.238.45
Japan Medical Dynamic Marketing, INC.2.38tn130.33bn1.76tn488.0013.460.6715.930.742548.3048.30880.53968.740.76090.68154.15--4.296.514.927.5363.6966.975.638.882.11--0.055218.268.786.74-10.68-8.52-2.959.24
EMvision Medical Devices Ltd94.23bn-34.30bn1.77tn----26.62--18.80-0.0449-0.04490.11860.07330.7954-------28.95-67.20-45.25-79.38-----36.40-175.99---35.200.3424--62.0870.4736.64------
Daiken Medical Co Ltd988.67bn93.47bn1.79tn188.0017.322.2815.581.8231.7531.75335.80240.850.87443.723.5951,314,050.008.277.1812.1210.4739.0542.969.459.251.52509.690.267673.266.991.25-14.32-6.79-20.77-0.9711
Philab Holdings Corp10.74bn-57.04bn1.81tn33.00------168.47-0.0999-0.09990.0188-0.02220.01950.11310.0800---10.50-14.09-82.08-39.7620.3049.92-537.65-150.590.4402-0.55951.05---70.18-2.4220.41------
Maja Agung Latexindo PT Tbk-100.00bn-100.00bn1.82tn167.00-------------------------------------------------12.44---46.53------
Aroa Biosurgery Ltd640.97bn-80.63bn1.83tn261.00--1.93--2.86-0.0221-0.02210.17560.25870.57641.693.18230,925.20-7.25-9.60-7.88-12.0884.4777.32-12.58-18.987.09-12.520.065--59.6841.6895.28--35.28--
Data as of May 16 2024. Currency figures normalised to Maja Agung Latexindo PT Tbk's reporting currency: Indonesian Rupiah IDR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.